MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

26 Jul 2024 Evaluate
The sales is pegged at Rs. 388.27 millions for the June 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 495.88 millions during the year-ago period.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 132.37  millions as against Rs. 177.21 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 190.75 millions from 245.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 388.27 495.88 -21.70 388.27 495.88 -21.70 1698.22 1483.85 14.45
Other Income 5.24 10.75 -51.26 5.24 10.75 -51.26 43.66 65.88 -33.73
PBIDT 190.75 245.81 -22.40 190.75 245.81 -22.40 831.00 802.17 3.59
Interest 0.66 0.25 164.00 0.66 0.25 164.00 2.29 1.76 30.11
PBDT 190.09 245.56 -22.59 190.09 245.56 -22.59 828.71 800.41 3.54
Depreciation 11.48 7.49 53.27 11.48 7.49 53.27 35.36 25.76 37.27
PBT 178.61 238.07 -24.98 178.61 238.07 -24.98 793.35 774.65 2.41
TAX 46.24 60.86 -24.02 46.24 60.86 -24.02 201.71 194.96 3.46
Deferred Tax 0.53 0.96 -44.79 0.53 0.96 -44.79 3.75 2.55 47.06
PAT 132.37 177.21 -25.30 132.37 177.21 -25.30 591.64 579.69 2.06
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 49.13 49.57 -0.89 49.13 49.57 -0.89 48.93 54.06 -9.48
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..